產(chǎn)品[
CRL-1993 HMy2.CIR 人B**母細胞
]資料
如果您對該產(chǎn)品感興趣的話(huà),可以
產(chǎn)品名稱(chēng):
CRL-1993 HMy2.CIR 人B**母細胞
產(chǎn)品型號:
CRL-1993
產(chǎn)品廠(chǎng)商:
美國標準生物品收藏中心(ATCC)
產(chǎn)品文檔:
無(wú)相關(guān)文檔
簡(jiǎn)單介紹
CRL-1993 HMy2.CIR 人B**母細胞,ATCC 細胞|細胞系|細胞株|腫瘤細胞|細胞|貼壁細胞|懸浮細胞|;細胞庫管理規范,提供的細胞株背景清楚,提供參考文獻和Z優(yōu)培養條件!
CRL-1993 HMy2.CIR 人B**母細胞
的詳細介紹
CRL-1993 HMy2.CIR 人B**母細胞
|
CRL-1993?
|
|
|
|
HMy2.CIR [C1R, HMy2.C1R]
|
|
P Cresswell
|
Biosafety Level:
|
2 [Cells contain Eptein-Barr Viral DNA sequences ]
|
|
frozen
|
Medium & Serum:
|
See Propagation
|
|
suspension
|
|
Homo sapiens (human)
|
|
lymphoblast
|
|
Cell Type: B lymphoblast;
|
|
In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
|
|
|
Amelogenin: X
CSF1PO: 6,10
D13S317: 11,13
D16S539: 9,13
D5S818: 10,13
D7S820: 7,12
THO1: 8
TPOX: 8
vWA: 17
|
|
ATCC complete growth medium: The base medium for this cell line is ATCC-formulated Iscove's Modified Dulbecco's Medium, Catalog No. 30-2005. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
Atmosphere: air, 95%; carbon dioxide (CO2), 5%
Temperature: 37.0°C
|
|
Protocol: Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 X 10(5) viable cells/ml.
Interval: Maintain between 2 X 10(5) and 1 X 10(6) viable cells/ml.
Medium Renewal: Every 2 to 3 days
|
|
Freeze medium: Complete growth medium supplemented with 5% (v/v) DMSO
Storage temperature: liquid nitrogen vapor phase
|
|
parental cell line:ATCC CRL-1621
derivative:ATCC CRL-2369
derivative:ATCC CRL-2370
derivative:ATCC CRL-2371
|
|
23312: Storkus WJ, et al. Reversal of natural killing susceptibility in target cells expressing transfected class I HLA genes. Proc. Natl. Acad. Sci. USA 86: 2361-2364, 1989. PubMed: 2784569
|
|